FDA Safety Changes: Prevacid NapraPAC, Epzicom, Forane
16th Nov 2006, 08:29 GMT
The FDA has approved revisions to the safety labeling for lansoprazole and naproxen, abacavir sulfate-lamivudine, and isoflurane volatile liquid. (CME) Medscape Medical News Laurie Barclay,Yael Waknine
Latest news from Medscape Neurology Headlines:
- Transparent Measures Are Essential for Coordinating and Rewarding Quality Improvement in Healthcare
- Improving Caregiver Well-being Delays Nursing Home Placement of AD Patients
- New Guideline Helps Diagnose Pediatric Status Epilepticus
- SALT 1 and 2: Tolvaptan Shows Promise in Hyponatremia
- Cognition Impaired After Bypass Surgery in Smokers
- Recognizing and Managing Stimulant Complications
- Oral Inhalation of Apomorphine May Relieve "Off" Periods in PD
- Creatine, Minocycline May Warrant Further Study in PD
- DEFUSE Study: MRI Predicts Ischemic Stroke Outcomes
- FDA Approvals: Allegra Oral Solution, Noxafil, Mirapex